Sector News

Novozymes’ CEO to step down as company looks to rejuvenate sales

October 16, 2019
Chemical Value Chain

Enzymes maker Novozymes, which has repeatedly cut its 2019 sales outlook, said on Tuesday that its chief executive Peder Holk Nielsen would step down early next year as it was time to “bring in new leadership”.

“Novozymes has been challenged in recent years and needs to deliver higher revenue growth,” it said in a statement.

The Danish firm, which among other things has been struggling with a weak U.S. ethanol production after floods in the Midwest this year, said it expected to announce a new CEO within a short period of time.

Shares in the company rose almost 4% in early trade.

By Stine Jacobsen

Source: Reuters

Join the discussion!

Your email address will not be published. Required fields are marked *

Related News

January 16, 2021

INEOS reduces planned Antwerp investment

Chemical Value Chain

LinkedIn Twitter Xing EmailINEOS has postponed work on the propane dehydrogenation (PDH) unit at its Antwerp, Belgium site, opting to prioritise construction of the cracker, a company spokesperson said on […]

January 10, 2021

TechnipFMC resumes plans to split company

Chemical Value Chain

TechnipFMC says it has resumed activities related to the previous announced separation of the company into two separate pure-play businesses, TechnipFMC and Technip Energies.

January 10, 2021

Solvay’s extended maternity, paternity & co-parent policy goes into effect

Chemical Value Chain

Solvay’s new policy increases maternity leave to 16 weeks. It is now available to any co-parent regardless of gender or sexual orientation; it also includes parents who adopt. The parent employed by Solvay will receive 100% of his or her salary during this leave period.

Send this to a friend